Hep Email Update Explaining Acute and Chronic Hepatitis C Hepatitis C is caused by a virus in the blood that primarily attacks the liver and causes inflammation leading to progressive liver damage. Advertisement Combination Therapy for Methamphetamine Use Found to Be Effective for Some The drugs naltrexone and bupropion are currently approved for other indications. Lanifibranor Both Resolves NASH and Reduces Liver Fibrosis The experimental therapy improved liver inflammation, fibrosis and metabolic parameters in six months. COVID-19 Raises Concerns of HIV and Hepatitis C in Boston “There is likely some community transmission going on that we aren’t able to capture as quickly.” #Coronavirus Get the latest updates! 2020 Top Hep Treatment Stories The link between COVID-19 and liver disease, along with research about NAFLD and NASH, topped the list. Advertisement Science News Lasting Immunity Found After Recovery From COVID-19 Combination Therapy for Methamphetamine Use Found to Be Effective for Some Modified Mediterranean Diet Reduces Fatty Liver Disease Lanifibranor Both Resolves NASH and Reduces Liver Fibrosis Newsfeed CDC Requires Face Masks on Public Transportation and at Transportation Hubs Millions Can Enroll in Obamacare Very Soon, Thanks to a Biden Directive Biden Hits the Ground Running on COVID-19, But Faces Daunting Challenges COVID-19 Raises Concerns of HIV and Hepatitis C in Boston Science News Lasting Immunity Found After Recovery From COVID-19 Combination Therapy for Methamphetamine Use Found to Be Effective for Some Modified Mediterranean Diet Reduces Fatty Liver Disease Lanifibranor Both Resolves NASH and Reduces Liver Fibrosis Newsfeed CDC Requires Face Masks on Public Transportation and at Transportation Hubs Millions Can Enroll in Obamacare Very Soon, Thanks to a Biden Directive Biden Hits the Ground Running on COVID-19, But Faces Daunting Challenges COVID-19 Raises Concerns of HIV and Hepatitis C in Boston

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@hepmag.com. Please remember to add update@hepmag.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: